NDAINJECTIONINJECTABLE
Approved
Mar 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed Yesterday · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
QUADRAMET is a radiopharmaceutical injection containing samarium SM-153 lexidronam pentasodium, approved in 1997 for palliative treatment of bone metastases. This radioisotope localizes to areas of increased osteogenesis in bone and delivers targeted radiation therapy to painful skeletal lesions. It is administered as an intravenous injection and represents a niche oncology product with decades of market history.
LOE Approaching
As an aging radiopharmaceutical approaching loss of exclusivity, the commercial team is likely compact and focused on defending against generic/competing radiopharmaceutical erosion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on QUADRAMET positions you in a declining-stage specialty product with minimal hiring momentum and limited growth trajectory. Roles are typically lean, focused on defending market position and managing payer relationships in a niche indication rather than building new capabilities.
Brand ManagerMedical Science Liaison
Worked on QUADRAMET at Remedy Plan Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.